Medistep Healthcare
MEDISTEP NSE
Medistep Healthcare
Consumer GoodsNSE: MEDISTEP Personal Care
Key Fundamentals
SMEPersonal CareConsumer GoodsMarket Cap
₹33.25 Cr
Volatility
High Risk
P/E Ratio
5.6
EBITDA
₹8.30 Cr
Return on Equity
15.82%
Debt to Equity
0.14
Book Value
₹26.62
52W High
₹35.5
52W Low
₹16.5
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Stock is trading at 0.85 times its book value
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 203 days.
Growth Rate
Revenue Growth
42.66% higher than
3Y
Net Income Growth
46.34% lower than
3Y
Cash Flow Change
—
ROE
-33.75% lower than
3Y
ROCE
-32.04% higher than
3Y
EBITDA Margin (Avg.)
3.46% higher than
3Y
Quarterly Results
| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 21.25 | 28.4 | 35.07 | 35.76 |
| Expenses | 18.96 | 25.09 | 31.09 | 31.49 |
| Operating Profit | 2.29 | 3.31 | 3.98 | 4.27 |
| OPM % | 10.78% | 11.65% | 11.35% | 11.94% |
| Other Income | 0 | 0 | 0 | 0.02 |
| Interest | 0.02 | 0.01 | 0 | 0.25 |
| Depreciation | 0.02 | 0.02 | 0.01 | 0.01 |
| PBT | 2.25 | 3.28 | 3.97 | 4.03 |
| Tax % | 25.33% | 25.3% | 25.19% | 25.06% |
| Net Profit | 1.69 | 2.46 | 2.97 | 3.01 |
| EPS in Rs | 1.61 | 2.35 | 2.09 | 2.12 |
Profit & Loss
| Particulars | Mar 2024 9m | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 31.6 | 49.65 | 70.83 |
| Expenses | 27.64 | 44.04 | 62.57 |
| Operating Profit | 3.96 | 5.61 | 8.26 |
| OPM % | 12.53% | 11.3% | 11.66% |
| Other Income | 0.01 | 0 | 0.02 |
| Interest | 0.06 | 0.04 | 0.26 |
| Depreciation | 0.02 | 0.03 | 0.03 |
| PBT | 3.89 | 5.54 | 7.99 |
| Tax % | 25.19% | 25.09% | 25.16% |
| Net Profit | 2.91 | 4.14 | 5.98 |
| EPS in Rs | 5.94 | 3.96 | 4.21 |
| Div. Payout % | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity Capital | 4.9 | 10.47 | 14.21 |
| Reserves | 6.79 | 6.89 | 23.62 |
| Borrowings | 0.33 | 0.64 | 5.18 |
| Other Liabilities | 2.93 | 5 | 7.29 |
| Total Liabilities | 14.95 | 23 | 50.3 |
| Fixed Assets | 0.15 | 0.14 | 0.12 |
| CWIP | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| Other Assets | 14.8 | 22.86 | 50.18 |
| Total Assets | 14.95 | 23 | 50.3 |
Cash Flow
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Operating | -7.11 | 0.02 | -19.48 |
| Investing | -0.15 | 0 | -0.01 |
| Financing | 7.24 | 1.28 | 18.79 |
| Net Cash Flow | -0.02 | 1.3 | -0.7 |
| Free Cash Flow | -7.26 | 0.02 | -19.49 |
| CFO/OP | -180 | 0 | -224 |
Ratios
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Debtor Days | 159 | 148 | 203 |
| Inventory Days | 12.41 | 9.23 | 36.52 |
| Days Payable | 18.81 | 20.55 | 21.57 |
| Cash Conversion Cycle | 152 | 137 | 218 |
| Working Capital Days | 134 | 117 | 191 |
| ROCE % | — | 37.18% | 27.04% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Medistep Healthcare insights
50 extracted metrics + investor summaries across FY24–FY26.
Documents
1
Copy of Newspaper Publication
28 Aug - Published 3rd AGM notice, e-voting details and book closure on August 28, 2026. 28 Aug - Published 3rd AGM notice, e-voting details and book closure on August 28, 2026.
2
Shareholders meeting
24 Aug - AGM scheduled for Sept 17, 2026; annual report sent and special resolution seeks Rs 100 crore Section 186 limit. 24 Aug - AGM scheduled for Sept 17, 2026; annual report sent and special resolution seeks Rs 100 crore Section 186 limit.
3
Outcome of Board Meeting
24 Aug - Board approved AGM notice, board report, and appointed auditors on 24 August 2026. 24 Aug - Board approved AGM notice, board report, and appointed auditors on 24 August 2026.
4
Change in Management
24 Aug - Board approved AGM notice, FY2026 report, and appointed auditors on August 24, 2026. 24 Aug - Board approved AGM notice, FY2026 report, and appointed auditors on August 24, 2026.
5
Updates
24 Aug - Book closure from 11-17 Sep 2026 for 3rd AGM; remote e-voting 14-16 Sep 2026. 24 Aug - Book closure from 11-17 Sep 2026 for 3rd AGM; remote e-voting 14-16 Sep 2026.
Frequently Asked Questions about Medistep Healthcare
What does Medistep Healthcare Ltd do?
Incorporated in June 2023, Medistep Healthcare Ltd manufactures and trades healthcare and personal care products.[1]
Where is Medistep Healthcare Ltd (MEDISTEP) listed?
Medistep Healthcare Ltd trades as MEDISTEP on the NSE.
Which sector does Medistep Healthcare Ltd belong to?
Medistep Healthcare Ltd is classified under the Consumer Goods sector, in the Personal Care industry.
What is the market capitalisation of Medistep Healthcare Ltd?
Medistep Healthcare Ltd has a market capitalisation of ₹33.25 Cr, which places it in the Small Cap band.
What is the PE ratio of Medistep Healthcare Ltd?
Medistep Healthcare Ltd trades at a PE ratio of 5.60, against a book value of ₹26.62 per share.
What is the 52-week high and low of Medistep Healthcare Ltd?
Over the last 52 weeks Medistep Healthcare Ltd has traded between ₹16.5 and ₹35.5.
What is the Return on Equity (ROE) of Medistep Healthcare Ltd?
Medistep Healthcare Ltd reported a return on equity of 15.82%. Its debt-to-equity ratio is 0.14.
Company Information
Incorporated in June 2023, Medistep Healthcare Ltd manufactures and trades healthcare and personal care products.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/MEDISTEP.md for Medistep Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.